Piper Sandler Maintains Overweight on Organon, Lowers Price Target to $32
Portfolio Pulse from Benzinga Newsdesk
Piper Sandler analyst David Amsellem has maintained an Overweight rating on Organon (NYSE:OGN) but lowered the price target from $33 to $32.
October 25, 2023 | 7:36 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Piper Sandler has maintained an Overweight rating on Organon but lowered the price target from $33 to $32.
The news is directly about Organon and its stock rating. Piper Sandler's decision to maintain an Overweight rating indicates a positive outlook for the company, but the lowering of the price target may create some uncertainty among investors, potentially impacting the stock's short-term performance.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100